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including 64 (0.62%) anomalous origin of coronary artery, 180 (1.72%)
anomalies of intrinsic coronary arterial anatomy, 24 (0.23%) coronary
artery ﬁstula, and 4 (0.04%) number anomalies of coronary artery.
Among anomalous origin of coronary artery, RCA originating from the
left sinus of Valsalva (n¼27, 0.26%), high take-off of the RCA (n¼14,
0.13%) and LCX originating from the right sV (n¼12, 0.11%) were the
top three types of anomalies. Among anomalies of intrinsic coronary
arterial anatomy, the frequencies of hypoplasia is 1.24%, aneurysms
0.41%, and coronary atresia 0.01%. No gender differences were pre-
sented in the frequencies of most CAAs, except that LCX originating
from the right sinus of Valsalva occurred more frequently in males
than females (0.11% vs. 0.01%, p¼0.027). Furthermore, clinical rele-
vance based classiﬁcations of CAAs were similar in the males and
females.
CONCLUSIONS 320-slice computed tomography can serve as a non-
invasive technique for clinical detection of CAAs.
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OBJECTIVES Mesenchymal stem cell (MSCs)-based therapy is under
investigation for treating acute myocardial infarction (MI) but is
limited due to poor engraftment and limited regenerative potential.
Integrin-linked kinase (ILK) overexpression enhances progenitor cells
homing, promotes cardiomyogenesis, reverses myocardial remodeling
and improves cardiac function. We sought to engineer MSCs with ILK
and evaluate their therapeutic potential on acute MI in a large-animal
model supposing a synergistic effect of MSC and ILK could be
achieved.
METHODS Minipigs underwent a 90-minute balloon occlusion of the
left anterior descending coronary artery followed by reperfusion. ILK-
engineered MSCs were intracoronary transplanted 71 days after oc-
clusion, as were vector-engineered MSCs and vehicle controls. Both
cells were GFP- and iron-labeled before transplantation and were
monitored in vivo by cardiac magnetic resonance imaging (CMR). CMR
was also used to measure global and regional left ventricular (LV)
function, scar size and perfusion.
RESULTS No impairment occurred in biological properties of MSCs
following iron labeling at 50mg/ml. Signiﬁcantly enhanced homing
capacity of MSCs following ILK modiﬁcation was revealed by MRI in
vivo and conﬁrmed by histological staining. Intracoronary trans-
plantation of ILK-engineered MSCs improves global LVEF by 7.8%
compared with baseline (P ¼ 0.03), and 11.7% when compared with
vehicle (P ¼ 0.02) 15 days post-implantation. Regional LV contractile
function was also recovered (P < 0.001), accompanied by substantially
reduced scar size (P < 0.001), myocardial remodeling (P < 0.05), cell
apoptosis (P < 0.001), and increased regional perfusion (P < 0.001)
and cardiac cell proliferation (P < 0.001) in ILK-MSC treated minipigs
versus vehicle controls. Vector-engineered MSC did not produce sig-
niﬁcant improvement in global LVEF or reduction in cardiac remod-
eling compared with baseline or vehicle controls, and generated less
extent of all other favorable effects compared with ILK-modiﬁed
MSCs.
CONCLUSIONS ILK-engineered allogeneic MSCs enhance regional
and global LV function, reverse the remodeling process and restore
regional perfusion with an improved homing capacity following
intracoronary transplantation. Engineering MSCs with ILK has great
potential implication for cell therapy in post-MI patients.
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OBJECTIVES The inﬂuence of body weight on mortality among pa-
tients with diabetes remains controversial. Therefore, we performed a
meta-analysis of pertinent studies.METHODS We searched OVID/MEDLINE, EMBASE and Cochrane da-
tabases for all reported studies, published before Dec 2014, which
investigated the relationship between body mass index (BMI) and
mortality in patients with diabetes. Summary estimates of hazard
ratios (HRs) were obtained with a random effects model. Univariate
meta-regressions were performed.
RESULTS Twenty studies including 250,016 patients with diabetes
were identiﬁed. The meta-analysis demonstrated a signiﬁcantly
reduced risk of all-cause mortality in overweight patients (HR 0.82,
95% CI 0.74 to 0.91, P<0.0001, and I2 ¼91.6%) as compared to normal
weight patients. The survival beneﬁts of obesity was only observed in
the elderly patients (HR 0.69, 95% CI 0.63 to 0.75, P<0.0001, and
I2 ¼50.4%), but not in the younger patients (HR 1.01, 95%CI 0.84 to
1.20, P¼0.96, I2 ¼80.1%). Moreover, meta-regression analysis indi-
cated that the beneﬁcial prognostic impacts on overweight (Coef-
ﬁcient¼0.030; p¼0.041) and obesity (Coefﬁcient ¼0.032; p¼0.010)
were attenuated with clinical follow-up duration.
CONCLUSIONS Our meta-analysis indicated a signiﬁcantly lower risk
of mortality in overweight patients with diabetes compared to normal
weight patients. However, the survival beneﬁts of obesity were only
observed among the elderly patients.
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OBJECTIVES Coronary artery disease (CAD) is a chronic inﬂammatory
disease involving the complex interplay between multiple genetic and
environmental factors. As a central regulator of inﬂammation, NF-kB
plays an important role in the development and progression of in-
ﬂammatory diseases. The aim of this study was to investigate whether
promoter polymorphisms in NFKB1 and NFKBIA gene contribute to
CAD in a Chinese Han population.
METHODS This is a case-control study. NFKB1 promoter poly-
morphism (-94ins/del ATTG) and NFKBIA promoter polymorphisms
(-881A/G, -826C/T, and -297C/T) were genotyped using TaqMan SNP
genotyping assays in 1140 Han CAD cases and 1156 Han CAD-negative
controls, and then NFKBIA haplotype blocks were reconstructed ac-
cording to our genotyping data.
RESULTS No statistical signiﬁcance was observed for the distribution
frequency of the NFKBIA -881 A/G, -826 C/T, or -219 C/T allele, ge-
notype and haplotype polymorphisms between CAD cases and con-
trols. None of the studied NFKBIA SNPs were associated with CAD.
There was signiﬁcant difference in the distribution of the genotypes
(P ¼ 0.001) and alleles (P¼0.001) of NFKB1-94ins/del polymorphism in
CAD cases and controls. The homozygous variant genotype of NFKB1-
94ins/del ATTG was consistently associated with increased risk of
CAD among all participants after adjustment for covariates (OR¼1.505,
95% CI 1.190 to 1.903, P ¼ 0.001).
CONCLUSIONS In our study, we did not detect any relationship be-
tween NFKBIA promoter polymorphisms and CAD. However, the -94
ins/del polymorphism in NFKB1 promoter affects the susceptibility for
CAD in Chinese Han population, providing a new insight into the
genetic basis of CAD in Chinese Han population.
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OBJECTIVES Thymus involution can contribute to immune distur-
bance. This study aimed to explore whether recent thymic export
